Goldberg MS - Search Results

1

Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.

Brock A, Krause S, Li H, Kowalski M, Goldberg MS, Collins JJ, Ingber DE. Brock A, et al. Among authors: goldberg ms. Sci Transl Med. 2014 Jan 1;6(217):217ra2. doi: 10.1126/scitranslmed.3007048. Sci Transl Med. 2014. PMID: 24382894 Free PMC article.

2

siRNA delivery for the treatment of ovarian cancer.

Goldberg MS. Goldberg MS. Methods. 2013 Sep 15;63(2):95-100. doi: 10.1016/j.ymeth.2013.01.007. Epub 2013 Feb 10. Methods. 2013. PMID: 23403216 Review.

3

Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases.

Park CG, Hartl CA, Schmid D, Carmona EM, Kim HJ, Goldberg MS. Park CG, et al. Among authors: goldberg ms. Sci Transl Med. 2018 Mar 21;10(433):eaar1916. doi: 10.1126/scitranslmed.aar1916. Sci Transl Med. 2018. PMID: 29563317

4

Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression.

Goldberg MS, Sharp PA. Goldberg MS, et al. J Exp Med. 2012 Feb 13;209(2):217-24. doi: 10.1084/jem.20111487. Epub 2012 Jan 23. J Exp Med. 2012. PMID: 22271574 Free PMC article.

5

Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.

Amoozgar Z, Goldberg MS. Amoozgar Z, et al. Among authors: goldberg ms. Adv Drug Deliv Rev. 2015 Aug 30;91:38-51. doi: 10.1016/j.addr.2014.09.007. Epub 2014 Oct 2. Adv Drug Deliv Rev. 2015. PMID: 25280471 Review.

6

Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps.

Park J, Wysocki RW, Amoozgar Z, Maiorino L, Fein MR, Jorns J, Schott AF, Kinugasa-Katayama Y, Lee Y, Won NH, Nakasone ES, Hearn SA, Küttner V, Qiu J, Almeida AS, Perurena N, Kessenbrock K, Goldberg MS, Egeblad M. Park J, et al. Among authors: goldberg ms. Sci Transl Med. 2016 Oct 19;8(361):361ra138. doi: 10.1126/scitranslmed.aag1711. Sci Transl Med. 2016. PMID: 27798263 Free PMC article.

7

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.

Schmid D, Park CG, Hartl CA, Subedi N, Cartwright AN, Puerto RB, Zheng Y, Maiarana J, Freeman GJ, Wucherpfennig KW, Irvine DJ, Goldberg MS. Schmid D, et al. Among authors: goldberg ms. Nat Commun. 2017 Nov 23;8(1):1747. doi: 10.1038/s41467-017-01830-8. Nat Commun. 2017. PMID: 29170511 Free PMC article.

8

Biotargeted nanomedicines for cancer: six tenets before you begin.

Goldberg MS, Hook SS, Wang AZ, Bulte JW, Patri AK, Uckun FM, Cryns VL, Hanes J, Akin D, Hall JB, Gharkholo N, Mumper RJ. Goldberg MS, et al. Nanomedicine (Lond). 2013 Feb;8(2):299-308. doi: 10.2217/nnm.13.3. Nanomedicine (Lond). 2013. PMID: 23394158 Free PMC article.

9

Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells.

Goldberg MS, Xing D, Ren Y, Orsulic S, Bhatia SN, Sharp PA. Goldberg MS, et al. Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):745-50. doi: 10.1073/pnas.1016538108. Epub 2010 Dec 27. Proc Natl Acad Sci U S A. 2011. PMID: 21187397 Free PMC article.

10

Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer.

Talekar M, Ouyang Q, Goldberg MS, Amiji MM. Talekar M, et al. Among authors: goldberg ms. Mol Cancer Ther. 2015 Jul;14(7):1521-31. doi: 10.1158/1535-7163.MCT-15-0100. Epub 2015 May 11. Mol Cancer Ther. 2015. PMID: 25964202 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page